Nuvaira, formerly known as Holaira, is a privately held medical device company that develops minimally invasive products to make breathing easier for patients suffering from obstructive lung diseases.
Nuvaira offers a Lung Denervation System to address chronic obstructive pulmonary diseases by treating overactive airway nerves during a minimally invasive procedure that targets the parasympathetic innervation of the lungs.
Nuvaira was founded in 2008 by Steve Dimmer & Martin Mayse. The company was formerly known as Holaira and changed its name to Nuvaira in June 2017. NUVAIRA has it's headquarter based in Minneapolis, Minnesota.
Nuvaira is developing a novel, catheter-based system to address chronic obstructive pulmonary disease, or COPD, by treating the overactive airway nerves in a procedure call Targeted Lung Denervation* (TLD).
Nuvaira is backed by investors including U.S. Venture Partners (USVP), Vertex Ventures, Vertex Ventures HC, & Advanced Technology Ventures among others.